Trump Admin Eyes Major GLP-1 Weight Loss Drug Coverage
The Trump administration is considering a five-year pilot program for Medicare & Medicaid to cover costly GLP-1 weight-loss drugs like Wegovy & Zepbound for millions, a significant policy shift.
/ 31 items
#LLY↓